January 17, 2015 to January 19, 2015
Double Tree by Hilton Hotel & Suites (Historic District), Charleston, SC
Terence J. Colgan, M.D.
Dr. Terence J. Colgan is Head of the Sections of Gynecological and Cytopathology at the Mount Sinai Hospital, Toronto, and a Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. His practice focuses on gynecologic pathology and cytopathology. His primary research areas are in the screening for gynecologic cancers and diagnosis of gynecologic malignancies. Both the Canadian Cancer Society Research Institute and the Canadian Institutes of Health Research have provided support for his collaborative research in biomarker discovery in endometrial and head neck cancers, and in fallopian tube carcinogenesis. He is currently serving as Associate Editor of American Cancer Society’sCancer (Cytopathology), and Chair of the College of American Pathologists’ Curriculum Committee. A synopsis of his professional activities can be found at: www.colganpath.ca
Megan S. Lim M.D., Ph. D
Dr. Megan S. Lim is a Professor and Director of the Hematopathology Section within the Department of Pathology at the University of Michigan Medical School. She has practiced hematopathology for the last 16 years with an interest in molecular diagnostic pathology. She has participated in numerous workshops and short courses for the Association for Clinical Pathology, College of American Pathologists, and the United States and Canadian Academy of Pathology as faculty and director. Her research is focused on utilizing comprehensive genomic, proteomic and metabolomics approaches to study the pathogenetic mechanisms involved in lymphoma.
Dr. Lim is a member of the Education Committee for the USCAP and has been involved in the training and education committees of the Association for Molecular Pathology and the Society of Hematopathology. She serves on Review Committees for the National Cancer Institute and the Veterans Administration. She is a member of the editorial board for the American Journal of Pathology, FASEB Journal, Laboratory Investigation and the Journal of Hematopathology. She serves in multiple leadership roles in national and international organizations; Vice-Chair of the Non-Hodgkin Lymphoma Disease Committee of the Children’s Oncology Research Group and Chair of the Hematopathology Division of Association of Molecular Pathology. She has published over 130 peer-reviewed research publications and has contributed more than 30 chapters in the topics of molecular pathology, proteomics and hematopathology.
Jeffrey Krane, M.D.
Dr. Jeffrey Krane is an Associate Professor of Pathology at Harvard Medical School in Boston, MA. He is a staff pathologist at Brigham and Women’s Hospital where he is the Associate Director of Cytology and the Chief of Head and Neck Pathology. Dr. Krane has special interests in salivary gland and thyroid cytopathology and HPV associated malignancy of the head and neck region and has given multiple local and national presentations on each of these topics. Dr. Krane values teaching opportunities aiming for a pragmatic approach to solving diagnostic challenges in cytology and surgical pathology. In his free time, he enjoys time with his wife and four teenage children and is a dedicated fan of baseball, film, and rock music.
Anna Berry, M.D.
Dr. Anna Berry is the Director of Molecular Diagnostics at CellNetix Pathology and Laboratories and Symbiodx, and the Scientific Director of the Personalized Medicine Program at the Swedish Cancer Institute. She is a graduate of the University of Nebraska Medical Center, and completed her post-graduate training at SUNY Upstate Medical University, the Medical College of Virginia, and the National Cancer Institute. Dr. Berry is Board Certified in Molecular Genetic Pathology, Cytopathology, Anatomic Pathology and Clinical Pathology, and served previously as the Director of Molecular Pathology and the Director of the Molecular Genetic Pathology fellowship training program at UCSF, where she retains an appointment as Associate Professor. Her clinical focus is making genomic technologies accessible to patients, and integrating genomic data into patient care. She serves on several national committees, including the Personalized Healthcare Committee of the College of American Pathologists, participates in several national genomics task forces and leads the Task Force for Genomics Education of Fellows for the Association for Molecular Pathology, and also represents the Association for Molecular Pathology at the Intersociety Coordinating Committee for Genomics Education at the NHGRI. Dr. Berry has given invited lectures and has taught CME courses at many locations across the country, as well as on-line.
Christina S. Kong, M.D.
Dr. Christina S. Kong specializes in both cytopathology and gynecologic surgical pathology, and is the Director of the Cytopathology Service and Cytopathology Fellowship at Stanford University. She trained in Anatomic and Clinical Pathology at UC San Francisco, and completed fellowship training in Surgical Pathology at Stanford and Cytopathology at UC San Francisco. Her research interests focus on squamous dysplasias and carcinomas of the anogenital tract and head and neck.